Ocular Allergies: Why Reaching for Eye Drops Isn't Always the Right Answer

Itchy, red, watery eyes are among the most common complaints in eye care — and among the most frequently self-managed in ways that make the underlying problem worse. Ocular allergies affect a significant portion of the population and share symptom overlap with dry eye disease, making accurate diagnosis more important than most patients realize before reaching for whatever is on the pharmacy shelf.¹

Your Annual Exam Is About More Than Your Prescription

Glasses and contacts are important — but they are only part of what we do at your annual wellness exam. Getting your prescription right improves your quality of life every day. Evaluating the health of your ocular surface — including signs of allergic inflammation — helps us identify conditions that, when left unmanaged, can affect your comfort, your contact lens tolerance, and your long-term ocular surface health.

If allergy-related findings are identified during your routine visit, we address them directly or schedule a follow-up to build a more structured management plan depending on severity.

What Ocular Allergies Actually Are

Allergic conjunctivitis is an immune-mediated inflammatory response of the conjunctiva — the clear tissue covering the white of the eye and inner eyelids — triggered by environmental allergens. When mast cells in the conjunctiva encounter a recognized allergen, they release histamine and other inflammatory mediators, causing the characteristic symptoms: itching, redness, tearing, and eyelid swelling.²

Seasonal allergic conjunctivitis is triggered by outdoor allergens — tree pollen in early spring, grass pollen through late spring and summer, and ragweed through fall. Pennsylvania's distinct four-season climate means patients often experience multiple distinct flare windows throughout the year.

Perennial allergic conjunctivitis is driven by year-round indoor allergens — dust mites, pet dander, and mold — and tends to produce milder but more persistent symptoms without the clear seasonal pattern.

Many patients experience both, with a perennial baseline punctuated by seasonal flares.

Allergies vs. Dry Eye: An Important Distinction

Ocular allergies and dry eye disease share significant symptom overlap — redness, irritation, tearing, and general ocular discomfort are common to both. They also frequently coexist in the same patient, which complicates self-diagnosis considerably.

The key distinguishing feature of allergic conjunctivitis is itch — true, prominent itching is the hallmark symptom and is not a primary feature of dry eye. Bilateral involvement, a history of systemic allergies, and a clear seasonal pattern also point toward an allergic etiology. Getting this distinction right matters because the treatments are meaningfully different, and applying the wrong one provides little relief while the actual condition goes unaddressed.³

The Visine Problem

Many patients manage ocular allergy symptoms long-term with OTC redness-relief drops — products containing vasoconstrictors like tetrahydrozoline (found in Visine and similar products). These drops reduce redness by constricting blood vessels, but they do not address the underlying allergic inflammation. With regular use, they cause rebound redness — a cycle in which the eyes become redder between doses, driving increased frequency of use.⁴ We consistently steer patients away from vasoconstrictor drops for this reason. They are not a treatment; they are a temporary cosmetic fix with a meaningful downside.

How We Evaluate and Treat Ocular Allergies

Our evaluation is clinical — focused on your symptom history, the appearance of the conjunctiva, and the presence and character of any papillary reaction on the inner eyelids. This gives us enough information to characterize severity and guide treatment without additional allergy testing in most cases.

For mild presentations, we start with OTC antihistamine/mast cell stabilizer drops. We carry Optase Allegro in office — a preservative-free dual-action drop that combines antihistamine and mast cell stabilizing activity. Pataday (olopatadine) is another highly effective OTC option with strong clinical evidence and once-daily dosing that works well for many patients.⁵

For moderate to severe flares, a short course of topical corticosteroids is appropriate to bring acute inflammation under control, followed by maintenance with OTC antihistamine drops thereafter. Steroids are used judiciously and with monitoring — not as a long-term standalone option.

For patients who do not respond adequately to topical management, or whose systemic allergy burden is significant enough to warrant a broader approach, a referral to an allergist for immunotherapy evaluation is occasionally worth discussing.

Allergies and Contact Lens Wear

Contact lens wearers with ocular allergies face a compounding challenge. Allergens and inflammatory mediators deposit on lens surfaces, increasing discomfort and reducing tolerable wear time. In susceptible patients, chronic lens-related antigen exposure can contribute to giant papillary conjunctivitis (GPC) — a more significant inflammatory response of the upper palpebral conjunctiva that can make lens wear increasingly difficult to tolerate.⁶

Management strategies include switching to daily disposable lenses to minimize deposit accumulation, reducing wear time during peak allergy seasons, and optimizing topical allergy treatment before and during lens wear. In flare periods, taking a temporary break from lens wear while the ocular surface settles is often the most practical short-term solution. We discuss these options based on your individual lens type, wearing schedule, and symptom pattern.

The Bottom Line

Ocular allergies are manageable — but not optimally with a vasoconstrictor from the convenience store. If your symptoms are recurring, worsening seasonally, interfering with contact lens wear, or not responding to OTC drops, a clinical evaluation gives us a clear picture of what is actually happening and the most effective path to relief. Contact us to schedule your visit.

For educational purposes only. Not a substitute for individualized medical care.

Ocular Allergies

1. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am. 2008;28(1):43–58. https://doi.org/10.1016/j.iac.2007.12.005

2. Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol.

2005;115(1):118–122. https://doi.org/10.1016/j.jaci.2004.10.042

3. Pflugfelder SC. Differential diagnosis of dry eye conditions. Adv Stud Ophthalmol. 2008;5(7):257–262.

4. Soparkar CN, et al. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants. Arch Ophthalmol. 1997;115(1):34–38.

https://doi.org/10.1001/archopht.1997.01100150036005

5. Leonardi A, et al. Olopatadine 0.1% versus levocabastine in allergic conjunctivitis. Curr Med Res Opin. 2003;19(4):321–328.

https://doi.org/10.1185/030079903125001710

6. Stapleton F, et al. Contact lens-related adverse events. Invest Ophthalmol Vis Sci. 2013;54(14):ORSF98–ORSF102. https://doi.org/10.1167/iovs.13-12592